Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease

Mitochondria provide energy to neurons through oxidative phosphorylation and eliminate Reactive Oxygen Species (ROS) through Superoxide Dismutase 1 (SOD1). Dysfunctional mitochondria, manifesting decreased activity of electron transport chain (ETC) complexes and high ROS levels, are involved in Alzh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pamela J. Yao, Erden Eren, Edward J. Goetzl, Dimitrios Kapogiannis
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6e9b8bf684d8429490e04949e31be9b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e9b8bf684d8429490e04949e31be9b8
record_format dspace
spelling oai:doaj.org-article:6e9b8bf684d8429490e04949e31be9b82021-11-25T16:49:21ZMitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease10.3390/biomedicines91115872227-9059https://doaj.org/article/6e9b8bf684d8429490e04949e31be9b82021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1587https://doaj.org/toc/2227-9059Mitochondria provide energy to neurons through oxidative phosphorylation and eliminate Reactive Oxygen Species (ROS) through Superoxide Dismutase 1 (SOD1). Dysfunctional mitochondria, manifesting decreased activity of electron transport chain (ETC) complexes and high ROS levels, are involved in Alzheimer’s disease (AD) pathogenesis. We hypothesized that neuronal mitochondrial dysfunction in AD is reflected in ETC and SOD1 levels and activity in plasma neuron-derived extracellular vesicles (NDEVs). We immunoprecipitated NDEVs targeting neuronal marker L1CAM from two cohorts: one including 22 individuals with early AD and 29 control subjects; and another including 14 individuals with early AD and 14 control subjects. In the first cohort, we measured levels of complexes I, III, IV, ATP synthase, and SOD1; in the second cohort, we measured levels and catalytic activity of complexes IV and ATP synthase. AD individuals had lower levels of complexes I (<i>p</i> < 0.0001), III (<i>p</i> < 0.0001), IV (<i>p</i> = 0.0061), and V (<i>p</i> < 0.0001), and SOD1 (<i>p</i> < 0.0001) compared to controls. AD individuals also had lower levels of catalytic activity of complex IV (<i>p</i> = 0.0214) and ATP synthase (<i>p</i> < 0.0001). NDEVs confirm quantitative and functional abnormalities in ECT complexes and SOD1 previously observed in AD models and during autopsy, opening the way for using them as biomarkers for mitochondrial dysfunction in AD.Pamela J. YaoErden ErenEdward J. GoetzlDimitrios KapogiannisMDPI AGarticleNADHoxidative phosphorylationAlzheimer’s diseasemitochondriaelectron transport chainSuperoxide Dismutase 1Biology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1587, p 1587 (2021)
institution DOAJ
collection DOAJ
language EN
topic NADH
oxidative phosphorylation
Alzheimer’s disease
mitochondria
electron transport chain
Superoxide Dismutase 1
Biology (General)
QH301-705.5
spellingShingle NADH
oxidative phosphorylation
Alzheimer’s disease
mitochondria
electron transport chain
Superoxide Dismutase 1
Biology (General)
QH301-705.5
Pamela J. Yao
Erden Eren
Edward J. Goetzl
Dimitrios Kapogiannis
Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
description Mitochondria provide energy to neurons through oxidative phosphorylation and eliminate Reactive Oxygen Species (ROS) through Superoxide Dismutase 1 (SOD1). Dysfunctional mitochondria, manifesting decreased activity of electron transport chain (ETC) complexes and high ROS levels, are involved in Alzheimer’s disease (AD) pathogenesis. We hypothesized that neuronal mitochondrial dysfunction in AD is reflected in ETC and SOD1 levels and activity in plasma neuron-derived extracellular vesicles (NDEVs). We immunoprecipitated NDEVs targeting neuronal marker L1CAM from two cohorts: one including 22 individuals with early AD and 29 control subjects; and another including 14 individuals with early AD and 14 control subjects. In the first cohort, we measured levels of complexes I, III, IV, ATP synthase, and SOD1; in the second cohort, we measured levels and catalytic activity of complexes IV and ATP synthase. AD individuals had lower levels of complexes I (<i>p</i> < 0.0001), III (<i>p</i> < 0.0001), IV (<i>p</i> = 0.0061), and V (<i>p</i> < 0.0001), and SOD1 (<i>p</i> < 0.0001) compared to controls. AD individuals also had lower levels of catalytic activity of complex IV (<i>p</i> = 0.0214) and ATP synthase (<i>p</i> < 0.0001). NDEVs confirm quantitative and functional abnormalities in ECT complexes and SOD1 previously observed in AD models and during autopsy, opening the way for using them as biomarkers for mitochondrial dysfunction in AD.
format article
author Pamela J. Yao
Erden Eren
Edward J. Goetzl
Dimitrios Kapogiannis
author_facet Pamela J. Yao
Erden Eren
Edward J. Goetzl
Dimitrios Kapogiannis
author_sort Pamela J. Yao
title Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
title_short Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
title_full Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
title_fullStr Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
title_full_unstemmed Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
title_sort mitochondrial electron transport chain protein abnormalities detected in plasma extracellular vesicles in alzheimer’s disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6e9b8bf684d8429490e04949e31be9b8
work_keys_str_mv AT pamelajyao mitochondrialelectrontransportchainproteinabnormalitiesdetectedinplasmaextracellularvesiclesinalzheimersdisease
AT erdeneren mitochondrialelectrontransportchainproteinabnormalitiesdetectedinplasmaextracellularvesiclesinalzheimersdisease
AT edwardjgoetzl mitochondrialelectrontransportchainproteinabnormalitiesdetectedinplasmaextracellularvesiclesinalzheimersdisease
AT dimitrioskapogiannis mitochondrialelectrontransportchainproteinabnormalitiesdetectedinplasmaextracellularvesiclesinalzheimersdisease
_version_ 1718412902692552704